DIO2 Thr92Ala Reduces Deiodinase-2 Activity and Serum-T3 Levels in Thyroid-Deficient Patients
Maria Grazia Castagna(University of Siena), Domenico Salvatore(CEINGE Biotecnologie Avanzate Franco Salvatore (Italy)), Monica Dentice(Federico II University Hospital), Carlotta Marzocchi(University of Siena), Corrado Garbi, Furio Pacini(University of Siena), Fabio Maino(University of Siena), Raffaele Ambrosio, Silvia Cantara(University of Siena), Tommaso Porcelli(University of Naples Federico II)
Cited by 155
Related Papers
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial
|The Lancet|2017|843
A Comparison of Recombinant Human Thyrotropin and Thyroid Hormone Withdrawal for the Detection of Thyroid Remnant or Cancer1
|The Journal of Clinical Endocrinology & Metabolism|1999|564
Impact of Proto-Oncogene Mutation Detection in Cytological Specimens from Thyroid Nodules Improves the Diagnostic Accuracy of Cytology
|The Journal of Clinical Endocrinology & Metabolism|2010|316
miRNA Targets: From Prediction Tools to Experimental Validation
|Methods and Protocols|2020|240
A Comparison of Short-Term Changes in Health-Related Quality of Life in Thyroid Carcinoma Patients Undergoing Diagnostic Evaluation with Recombinant Human Thyrotropin Compared with Thyroid Hormone Withdrawal
|The Journal of Clinical Endocrinology & Metabolism|2006|198